Results and updates covered here include news from two small AIM companies in the retail sector, which have delivered a terrific performance over recent months; but can the good times continue? Elsewhere, it was an overwhelmingly positive day for updates, for a change!
Strong trading from AMS
Advanced Medical Solutions (AIM: AMS), the world-leading specialist in tissue-healing technologies, confirmed strong trading for its financial year ending 31 December 2022 with revenues and profits expected to be in line with market expectations.
AMS made good progress during 2022 in its regulatory and clinical programmes including the US approval of LiquiBand® XL in May and the submission of a PMA for LiquiBandFix8® in October. The initial European…
Access the all latest company comments on Investor's Champion.
Not yet registered? It's free to register. Register now.
Register on Investor's Champion
Access the all latest company comments on Investor's Champion.
Premium Content
Premium content provides more in-depth information on fascinating investment stories and research to help make your money go further.
Access Premium Content through individual credits (we only want you to read what you are interested in) or through an annual subscription, which works out as only 25p per day – a small price to guide you through the investing maze!
Subscription
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team
Credits
Get access to our premium content for as little as £3.20 per article.
